Champions Oncology (CSBR) Prepaid Assets (2011 - 2026)
Champions Oncology (CSBR) posted quarterly Prepaid Assets of $1.2 million for Q2 2026, down 14.61% year-over-year from $1.4 million in Q2 2025, and up 17.96% quarter-over-quarter from $991000.0 in Q1 2026.
Champions Oncology (CSBR) Prepaid Assets (2011 - 2026) Analysis & Trends
Champions Oncology's Prepaid Assets history runs 16 years deep, the most recent figure standing at $1.2 million for Q2 2026.
- In Q2 2026, Prepaid Assets fell 14.61% year-over-year to $1.2 million; the TTM figure through Apr 2026 stood at $1.2 million (down 14.61% YoY), while the FY2026 annual figure was $1.2 million, down 14.61% from the prior year.
- Prepaid Assets for Q2 2026 stood at $1.2 million, up from $991000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.5 million in Q2 2024, with the low at $561000.0 in Q1 2022.
- The 5-year median for Prepaid Assets is $1.0 million (2023), against an average of $1.0 million.
- Peak annual rise in Prepaid Assets reached 48.49% in 2025, while the deepest fall reached 14.61% in 2025.
- Champions Oncology's Prepaid Assets stood at $834000.0 in 2022, then fell by 6.47% to $780000.0 in 2023, then gained by 10.26% to $860000.0 in 2024, then soared by 48.49% to $1.3 million in 2025, then declined by 8.46% to $1.2 million in 2026.
- Business Quant data shows CSBR's Prepaid Assets at $1.2 million in Q2 2026, $991000.0 in Q1 2026, and $1.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Champions Oncology | 68.61 Mn | 68.61 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.17 Mn |
| Jan 31, 2026 | 991,000.00 |
| Oct 31, 2025 | 1.28 Mn |
| Jul 31, 2025 | 1.22 Mn |
| Apr 30, 2025 | 1.37 Mn |
| Jan 31, 2025 | 713,000.00 |
| Oct 31, 2024 | 860,000.00 |
| Jul 31, 2024 | 1.25 Mn |
| Apr 30, 2024 | 1.50 Mn |
| Jan 31, 2024 | 835,000.00 |
| Oct 31, 2023 | 780,000.00 |
| Jul 31, 2023 | 1.11 Mn |
| Apr 30, 2023 | 1.33 Mn |
| Jan 31, 2023 | 661,000.00 |
| Oct 31, 2022 | 834,000.00 |
| Jul 31, 2022 | 958,000.00 |
| Apr 30, 2022 | 1.14 Mn |
| Jan 31, 2022 | 561,000.00 |
| Oct 31, 2021 | 731,000.00 |
| Jul 31, 2021 | 864,000.00 |